THINK Surgical nets up to $65m with Symbiotic Capital debt facility

Think’s flagship product is TMINI, a handheld robotics system for TKA procedures. Think’s flagship product is TMINI, a handheld robotics system for TKA procedures. THINK will apply the financing towards advancing the commercialisation of its TMINI surgical robotics system for TKA procedures. Credit: Tada Images/Shutterstock.com THINK Surgical has secured up to $65m in growth capital after entering into a debt facility arrangement with Symbiotic Capital, setting the company up with funds to advance commercial activities surrounding its robotics system and companion software for total knee arthroplasty (TKA) procedures. Under the agreement, the California-based company will obtain an initial $25m, an…

Source: Medical Device Network